Tapotoclax is under clinical development by Amgen and currently in Phase I for M...
Tapotoclax is under clinical development by Amgen and currently in Phase I for C...
Vorolanib is under clinical development by EyePoint Pharmaceuticals and currentl...
Monoclonal Antibody Conjugate 3 to Target EGFR for Oncology is under clinical de...
(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical...
(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical...
(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical...
AFM-24I is under clinical development by Affimed and currently in Phase II for M...
INCB-57643 is under clinical development by Incyte and currently in Phase II for...
A university in Florida has been criticized for allowing a lecture that conveyed...
The need-to-know in biotech this morning: —The arrival of Scion Life Sciences —G...
Eli Lilly is worried a deal to expand production of Novo Nordisk's weight-loss d...
Three biotech VC veterans, including one of the co-founders of radiopharma succe...
AI models can help speed up some parts of the drug development process but exper...
As leaders across federal agencies swiftly advance regulations for AI in health ...
While health care developers are experimenting with Apple Vision Pro, they say i...
